July 2006

HIV Eosinophilic Folliculitis in Uganda—Reply

Author Affiliations

Copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2006

Arch Dermatol. 2006;142(7):927-947. doi:10.1001/archderm.142.7.934-c

In reply

Dr Colebunders and colleagues suggest that HAART alone might be as efficient as HAART and 0.1% tacrolimus therapy in controlling HIV-EF. In our experience, based on 15 cases to date, we have consistently observed accelerated improvement when we have used the combination of HAART and 0.1% tacrolimus compared with HAART alone.1